Skip to content
Delayed ~15 min

HYPR HYPERFINE CLASS A

Health Care · Russell 2000

Next earnings: Mon 9 Nov 2026 · after market close

What 8 analyst firms say about HYPERFINE CLASS A: their latest ratings, price targets and how far the stock is from them. How it works

0.72 USD+0.03 (+4.98%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+180.8%to the avg target 2.02 USD+1.30 USD
Buy 5 · Hold 1 · Sell 0

6 rated views · 8 analyst/firm records · 8 firms

Latest report27 Oct 2026avg report date 11 Sep
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
  • Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD

Recent analyst activity · last 90 days

Our tracked history has 9 reports on HYPR from 6 analyst firms in the last 90 days (8 firms in the past year).

Comparing each firm's latest target with its previous one: 2 left it unchanged and 2 have their first observed target in the past year.

No firm's latest available rating differs from its previous one.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
B Riley SecuritiesYuan ZhiBuy10 Aug 20261.60 USD
BTIGMarie ThibaultBuy22 Sep 20262.00 USD
Lake Street Capital MarketsFrank TakkinenBuy1 Jul 20262.50 USD
Loop CapitalAlex Nowak—27 Oct 20262.00 USD
Lucid Cap MktsUnnamed analystBuy27 Oct 2026—
Lucid Capital MarketsAlexander NowakBuy27 Oct 20262.00 USD
Weiss RatingsUnnamed analyst—15 Oct 2026—
Data feed RESEARCHResearch TeamHold19 Mar 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 08:12 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.